Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 106151-106200 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03992417
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
N/A
Active, not recruiting
955 participants
Started: Jun 11, 2019 · Completed: Mar 31, 2027
1 condition
2 sponsors
114 locations
NCT03742245
Olaparib in Combination with Vorinostat in Patients with Relapsed/Refractory And/or Metastatic Breast Cancer
PHASE1
Recruiting
28 participants
Started: Jun 11, 2019 · Completed: Mar 1, 2026
2 conditions
3 sponsors
1 location
NCT03985176
Delayed Cerebral Ischaemia and Coagulation Alterations After Aneurysmal Subarachnoid Haemorrhage
N/A
Active, not recruiting
62 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03973372
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
N/A
Active, not recruiting
852 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2027
2 conditions
16 sponsors
14 locations
NCT03978767
Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial
PHASE2
Recruiting
286 participants
Started: Jun 10, 2019 · Completed: Jun 1, 2025
2 conditions
1 sponsor
1 location
NCT03735667
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NA
Active, not recruiting
1,948 participants
Started: Jun 10, 2019 · Completed: Sep 30, 2034
1 condition
1 sponsor
75 locations
NCT03294460
Nicotinic Receptor Genetic Variation and Alcohol Reward
PHASE1
Recruiting
128 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03975907
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
PHASE1/PHASE2
Active, not recruiting
121 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition
14 sponsors
23 locations
NCT03741101
Treatment of NF1-related Plexiform Neurofibroma With Trametinib
PHASE2
Active, not recruiting
15 participants
Started: Jun 10, 2019 · Completed: Dec 15, 2024
3 conditions
2 sponsors
1 location
NCT03968614
Electrical DN as an Adjunct to Eccentric Exercise, Stretching + MT for Achilles Tendinopathy
NA
Recruiting
110 participants
Started: Jun 10, 2019 · Completed: May 1, 2026
1 condition
2 sponsors
1 location
NCT03911557
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
PHASE2
Active, not recruiting
14 participants
Started: Jun 8, 2019 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03948490
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
NA
Recruiting
97 participants
Started: Jun 7, 2019 · Completed: Mar 31, 2026
1 condition
3 sponsors
1 location
NCT03839342
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
PHASE2
Active, not recruiting
26 participants
Started: Jun 7, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03627988
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
PHASE2
Active, not recruiting
65 participants
Started: Jun 7, 2019 · Completed: May 31, 2026
1 condition
1 sponsor
2 locations
NCT03745339
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
N/A
Recruiting
150 participants
Started: Jun 7, 2019 · Completed: Oct 1, 2026
2 conditions
1 sponsor
1 location
NCT03793166
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
PHASE3
Active, not recruiting
1,175 participants
Started: Jun 7, 2019 · Completed: Sep 15, 2026
9 conditions
1 sponsor
864 locations
NCT03943173
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
EARLY_PHASE1
Active, not recruiting
15 participants
Started: Jun 7, 2019 · Completed: Dec 27, 2025
31 conditions
2 sponsors
1 location
NCT03965325
FOcUs on Colorectal CAncer oUtcomes: Long-Term Study
N/A
Active, not recruiting
133 participants
Started: Jun 7, 2019 · Completed: Jun 6, 2025
1 condition
1 sponsor
1 location
NCT04040530
Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours
N/A
Active, not recruiting
187 participants
Started: Jun 7, 2019 · Completed: Feb 7, 2026
2 conditions
3 sponsors
2 locations
NCT03564561
Natural History of Pompe Disease
N/A
Recruiting
20 participants
Started: Jun 7, 2019 · Completed: Mar 31, 2033
1 condition
1 sponsor
1 location
NCT04088292
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
PHASE3
Active, not recruiting
210 participants
Started: Jun 6, 2019 · Completed: Nov 30, 2024
1 condition
5 sponsors
4 locations
NCT03779711
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
PHASE2
Active, not recruiting
95 participants
Started: Jun 6, 2019 · Completed: Feb 28, 2026
1 condition
9 sponsors
8 locations
NCT03817502
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
PHASE3
Recruiting
330 participants
Started: Jun 6, 2019 · Completed: Dec 15, 2026
1 condition
1 sponsor
57 locations
NCT04183699
Optimizing the Number of Systematic COres During a MRI Target Biopsy
NA
Recruiting
265 participants
Started: Jun 6, 2019 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05678530
Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
N/A
Recruiting
400 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2026
1 condition
1 sponsor
15 locations
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
N/A
Active, not recruiting
2,800 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2027
1 condition
9 sponsors
3 locations
NCT03819101
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
PHASE3
Recruiting
1,210 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2042
1 condition
2 sponsors
23 locations
NCT03625752
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
NA
Active, not recruiting
60 participants
Started: Jun 6, 2019 · Completed: May 7, 2026
2 conditions
2 sponsors
2 locations
NCT04302220
Myopic Optic Neuropathy in Chinese High Myopia Population
N/A
Active, not recruiting
813 participants
Started: Jun 6, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03923270
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
PHASE1
Active, not recruiting
25 participants
Started: Jun 6, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04115761
Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
PHASE2
Recruiting
24 participants
Started: Jun 6, 2019 · Completed: Dec 30, 2026
1 condition
1 sponsor
3 locations
NCT04870866
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
PHASE2
Active, not recruiting
13 participants
Started: Jun 5, 2019 · Completed: Jun 16, 2027
1 condition
9 sponsors
2 locations
NCT03979235
Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation
N/A
Recruiting
40 participants
Started: Jun 5, 2019 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT03959215
Back in the Game: a Smartphone Application to Support Athletes Returning to Sport After Serious Injury
NA
Active, not recruiting
169 participants
Started: Jun 5, 2019 · Completed: Jul 31, 2024
1 condition
6 sponsors
7 locations
NCT03875781
Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer
PHASE3
Recruiting
540 participants
Started: Jun 5, 2019 · Completed: Dec 5, 2026
2 conditions
1 sponsor
1 location
NCT03598309
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
PHASE2
Active, not recruiting
19 participants
Started: Jun 5, 2019 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT03766009
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
NA
Active, not recruiting
627 participants
Started: Jun 5, 2019 · Completed: Dec 15, 2026
4 conditions
3 sponsors
58 locations
NCT04265638
Exercise Intervention in Adolescent and Young Adult Cancer Survivors
NA
Recruiting
66 participants
Started: Jun 5, 2019 · Completed: May 31, 2024
2 conditions
1 sponsor
3 locations
NCT03889795
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
PHASE1
Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Dec 30, 2027
2 conditions
1 sponsor
1 location
NCT04479696
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
NA
Recruiting
117 participants
Started: Jun 5, 2019 · Completed: Feb 2, 2027
3 conditions
2 sponsors
1 location
NCT03719131
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
PHASE2
Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Jun 30, 2026
8 conditions
2 sponsors
1 location
NCT03612232
Cabozantinib in Advanced Adrenocortical Carcinoma
PHASE2
Active, not recruiting
37 participants
Started: Jun 4, 2019 · Completed: Apr 30, 2025
1 condition
1 sponsor
2 locations
NCT04928664
Continuous vs Liposomal Bupivacaine Interscalene Block for Proximal Humeral Fracture (CLIP)
PHASE4
Recruiting
78 participants
Started: Jun 4, 2019 · Completed: Aug 1, 2024
1 condition
1 sponsor
2 locations
NCT03969004
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
PHASE3
Active, not recruiting
415 participants
Started: Jun 4, 2019 · Completed: Mar 26, 2028
1 condition
1 sponsor
166 locations
NCT05362721
PV Loop & Coarctation Study
N/A
Recruiting
20 participants
Started: Jun 4, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT05589402
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
PHASE1
Recruiting
30 participants
Started: Jun 4, 2019 · Completed: Jun 4, 2026
3 conditions
1 sponsor
1 location
NCT04446442
Cerebellar tDCS in Children With Autism Spectrum Disorder
NA
Recruiting
60 participants
Started: Jun 4, 2019 · Completed: Mar 31, 2026
1 condition
2 sponsors
2 locations
NCT03727880
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
PHASE2
Active, not recruiting
36 participants
Started: Jun 4, 2019 · Completed: Jan 15, 2026
2 conditions
3 sponsors
3 locations
NCT03915951
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
98 participants
Started: Jun 4, 2019 · Completed: Oct 30, 2025
1 condition
1 sponsor
159 locations
NCT03964311
Risk for Short-term Adverse Events in Older Emergency Department Users
NA
Active, not recruiting
5,000 participants
Started: Jun 4, 2019 · Completed: Jan 1, 2025
4 conditions
1 sponsor
1 location
Previous
1
More pages
2121
2122
2123
2124
2125
2126
2127
More pages
2369
Next